ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatm…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
ALX Oncology Holdings Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
ALX Oncology Holdings Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of ALX Oncology Holdings Inc..